Considering the role of the serotonin and angiotensin systems in cardiac hypertrophy, we hypothesized that DNA variants in the 5-HT2A, 5-HTT, AGT, ACE, and AT1R genes could influence the risk for LVH. The gene discussed is AGT; the disease is cardiac hypertrophy.